Literature DB >> 22414967

National patterns in human papillomavirus vaccination: an analysis of the National Survey of Family Growth.

Gelareh Sadigh1, Amanda F Dempsey, Mack Ruffin, Ken Resnicow, Ruth C Carlos.   

Abstract

Human papillomavirus (HPV) vaccine has shown effectiveness for girls and young women. Despite this, there are population disparities in vaccine utilization rates. The purpose of this study was to evaluate maternal correlates of HPV vaccination among their adolescent daughters using a nationally-representative population-based sample, emphasizing race/ethnicity-specific disparities and barriers. Mothers of 9-18 y-old girls having heard of HPV vaccine and completing the HPV vaccine survey module from the 2006-2008 National Survey of Family Growth (NSFG) (n = 444) were analyzed for maternally-reported adolescent HPV vaccination and maternal intent to vaccinate her adolescent daughter if no dose had been received. Correlates of uptake and intent were examined using multivariate logistic regression. 27% of mothers (n = 98) reported that their daughters were vaccinated against HPV. Independent correlates of vaccination included African-American race (adjusted odds ratio (AOR),0.29; 95% confidence interval (CI),0.11-0.77), and living below the poverty level (AOR,4.43; 95%CI, 1.53-12.82). 46% (n = 152) of mothers of non-vaccinated daughters intended to vaccinate them. Correlates of maternal intention included maternal pelvic exam history (AOR,0.06; 95%CI, 0.007-0.51), multiple male lifetime sexual partners (AOR,3.22 ; 95% CI, 1.34-7.76), religiosity (AOR,0.37; 95% CI,0.16-0.87) and acceptability of premarital sex among 18 y-olds (AOR,2.45; 95% CI, 1.16-5.20). In conclusion, HPV vaccination initiation among adolescent daughters of mothers participating in the NSFG continues to lag among African-American participants. However, no racial/ethnic differences in maternal intent-to-vaccinate her daughter were detected. Future interventions need to address specific maternal barriers to vaccine uptake and how these may differ from vaccine intention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414967     DOI: 10.4161/hv.18456

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  10 in total

1.  Racial disparities in human papillomavirus vaccination: does access matter?

Authors:  Amanda Gelman; Elizabeth Miller; Eleanor Bimla Schwarz; Aletha Y Akers; Kwonho Jeong; Sonya Borrero
Journal:  J Adolesc Health       Date:  2013-08-27       Impact factor: 5.012

2.  Initiation of Human Papillomavirus Vaccination Among Predominantly Minority Female and Male Adolescents at Inner-City Community Health Centers.

Authors:  Rula M Btoush; Diane R Brown; Sushanna Fogarty; Dennis P Carmody
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

3.  HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center.

Authors:  Rula M Wilson; Diane R Brown; Dennis P Carmody; Sushanna Fogarty
Journal:  J Community Health       Date:  2015-06

4.  Overcoming barriers to HPV vaccination: A randomized clinical trial of a culturally-tailored, media intervention among African American girls.

Authors:  Ralph J DiClemente; Colleen Crittenden Murray; Tracie Graham; Julia Still
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

5.  The factors associated with maternal consent to human papillomavirus vaccination among adolescents in Israel.

Authors:  Rana Shibli; Shmuel Rishpon
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

6.  Does intention to recommend HPV vaccines impact HPV vaccination rates?

Authors:  Kristen A Feemster; Maria Middleton; Alexander G Fiks; Sarah Winters; Sara B Kinsman; Jessica A Kahn
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

7.  Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.

Authors:  Jacqueline Hirth; Christine J McGrath; Yong-Fang Kuo; Richard E Rupp; Jonathan M Starkey; Abbey B Berenson
Journal:  Vaccine       Date:  2018-10-28       Impact factor: 3.641

8.  Individualism, acceptance and differentiation as attitude traits in the public's response to vaccination.

Authors:  Baruch Velan; Valentina Boyko; Liat Lerner-Geva; Arnona Ziv; Yaakov Yagar; Giora Kaplan
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

9.  Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah.

Authors:  Julia Bodson; Andrew Wilson; Echo L Warner; Deanna Kepka
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

10.  Incremental benefits of male HPV vaccination: accounting for inequality in population uptake.

Authors:  Megan A Smith; Karen Canfell
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.